St. Mary’s Medical Center is the First Hospital in Florida to Treat Stroke Patients with Novel TIGERTRIEVERÔ Stroke Device

St. Mary’s Medical Center is the first hospital in Florida to remove a blood clot in the brain using Rapid Medical’s new TIGERTRIEVER device—the only clot removal tool that is adjustable inside the brain. TIGERTRIEVER enables neuro interventionalists to better remove blood clots and restore blood flow to the brain following a stroke—a condition that devastates 800,000 Americans annually. Dr. Ali Malek, medical director of the comprehensive stroke center at the hospital, performed the procedure.

“This new technology gives our team an even better opportunity to capture clots that form in the brain so we can treat someone having a stroke as quickly as possible,” said Dr. Ali Malek. “Using the TIGERTRIEVER is a breakthrough in our community, and we look forward to providing the level of care needed for patients who come to our comprehensive stroke center.”

TIGERTRIEVER is the first and only adjustable clot retriever, providing physicians with greater control and adaptability to varying patient anatomy and circumstances. While viewing the device under x-ray guidance, physicians can adjust it to match the vessel size and better capture the clot.

“This is just another example as to why St. Mary’s Medical Center continues to be at the forefront of neurologic care when it comes to treating strokes,” said Cynthia McCauley, chief executive officer of St. Mary’s Medical Center & Palm Beach Children’s Hospital. “We look forward to using this new technology to treat our patients so they can receive the quality care they deserve when they are brought to our hospital.”

St. Mary’s Medical Center is an award-winning Comprehensive Stroke Center providing quality care in stroke prevention, stroke management, and stroke rehabilitation. Our center is equipped with some of the latest diagnostic and therapeutic advances to quickly and accurately diagnose and treat stroke patients. Patients benefit from a range of comprehensive medical, surgical and minimally invasive treatment options, as well as access to clinical trials and research.

For more information on our comprehensive services, go to www.stmarysmc.com or call 561-844-6300.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The AGENT DCB is available in Europe, parts of Asia Pacific and Latin America for the treatment of patients with ISR and previously untreated small vessel coronary disease. Boston Scientific plans to launch the technology in the U.S. in the coming months.
Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy